{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:00:32Z","timestamp":1791082832877,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jaci.2024.09.017","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:27:02Z","timestamp":1727418422000},"page":"479-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-3232","authenticated-orcid":false,"given":"H. Mark","family":"Kenney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Berdyshev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelma C.","family":"Chiesa Fuxench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peck Y.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Schlievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-667X","authenticated-orcid":false,"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2024.09.017_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jaci.2024.09.017_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic Dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Chiesa Fuxench","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","article-title":"The atopic march: critical evidence and clinical relevance","volume":"120","author":"Hill","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"3 pt 2","key":"10.1016\/j.jaci.2024.09.017_bib6","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0091-6749(99)70051-5","article-title":"Pathogenesis of atopic dermatitis","volume":"104","author":"Leung","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2024.09.017_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/1523-1747.ep12470383","article-title":"Evidence that the corneocyte has a chemically bound lipid envelope","volume":"88","author":"Swartzendruber","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jchromb.2007.02.030","article-title":"Separation and mass spectrometric characterization of covalently bound skin ceramides using LC\/APCI-MS and nano-ESI-MS\/MS","volume":"852","author":"Farwanah","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jaci.2024.09.017_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1467-2494.2006.00324.x","article-title":"A new covalently bound ceramide from human stratum corneum \u2013\u03c9-hydroxyacylphytosphingosine","volume":"28","author":"Hill","year":"2006","journal-title":"Int J Cosmet Sci"},{"key":"10.1016\/j.jaci.2024.09.017_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jid.2019.09.013","article-title":"The cornified envelope-bound ceramide fraction is altered in patients with atopic dermatitis","volume":"140","author":"Boiten","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib12","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1194\/jlr.P030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"Janssens","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2024.09.017_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2024.09.017_bib14","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1038\/jid.2010.161","article-title":"Changes in\u00a0the\u00a0ceramide profile of atopic dermatitis patients","volume":"130","author":"Ishikawa","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/exd.12293","article-title":"The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients","volume":"23","author":"van Smeden","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib16","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1074\/jbc.M310529200","article-title":"Role for ELOVL3 and fatty acid chain length in development of hair and skin function","volume":"279","author":"Westerberg","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2024.09.017_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jaci.2024.09.017_bib18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41419-018-1226-1","article-title":"Elovl6 regulates mechanical damage-induced keratinocyte death and skin inflammation","volume":"9","author":"Nakamura","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaci.2024.09.017_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fendo.2020.00483","article-title":"Ceramide synthases are attractive drug targets for treating metabolic diseases","volume":"11","author":"Raichur","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaci.2024.09.017_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","article-title":"The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice","volume":"49","author":"Guillou","year":"2010","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jaci.2024.09.017_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2023.02.013","article-title":"Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis","volume":"151","author":"Berdyshev","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jaci.2024.02.014","article-title":"Skin biomarkers predict the development of food allergy in early life","volume":"153","author":"Berdyshev","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.alit.2021.11.001","article-title":"Skin microbiome of atopic dermatitis","volume":"71","author":"Koh","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2024.09.017_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943640","article-title":"Atopic dermatitis: is innate or adaptive immunity in control? A\u00a0clinical perspective","volume":"13","author":"Ong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2133.1974.tb06447.x","article-title":"Staphylococcus aureus in the lesions of atopic dermatitis","volume":"90","author":"Leyden","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jid.2018.03.1517","article-title":"Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype","volume":"138","author":"Simpson","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2010.07.024","article-title":"Characterization and\u00a0structure identification of an antimicrobial peptide, hominicin, produced by\u00a0Staphylococcus hominis MBBL 2-9","volume":"399","author":"Kim","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2024.09.017_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials\u00a0from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2024.09.017_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00930-22","article-title":"The ubiquitous human skin commensal Staphylococcus hominis protects against opportunistic pathogens","volume":"13","author":"Severn","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jaci.2024.09.017_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2024.09.017_bib31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.09.017_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-022-00685-0","article-title":"Dupilumab provides acceptable safety and sustained efficacy for up to 4 years in an open-label study of adults with moderate-to-severe atopic dermatitis","volume":"23","author":"Beck","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"10356","key":"10.1016\/j.jaci.2024.09.017_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(22)01539-2","article-title":"Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Paller","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.09.017_bib34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaci.2023.05.026","article-title":"Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment","volume":"152","author":"Simpson","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.09.017_bib35","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1111\/all.15432","article-title":"Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis","volume":"77","author":"Berdyshev","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.09.017_bib36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archderm.1983.01650340050019","article-title":"Staphylococcus aureus and atopic dermatitis","volume":"119","author":"Dahl","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2024.09.017_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nchembio.1059","article-title":"Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy","volume":"8","author":"Sentelle","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jaci.2024.09.017_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13954","article-title":"Alterations of lipid-mediated mitophagy result in aging-dependent sensorimotor defects","volume":"22","author":"Oleinik","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.jaci.2024.09.017_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113081","article-title":"The heat shock protein Hsp27 controls mitochondrial function by modulating ceramide generation","volume":"42","author":"Boyd","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2024.09.017_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2023.109697","article-title":"Staphylococcus aureus induces mitophagy to promote its survival within bovine mammary epithelial cells","volume":"280","author":"Xu","year":"2023","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.jaci.2024.09.017_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jcmm.17664","article-title":"PINK1\/Parkin-mediated mitophagy enhances the survival of Staphylococcus aureus in bovine macrophages","volume":"27","author":"Zhou","year":"2023","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jaci.2024.09.017_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127421","article-title":"Staphylococcus aureus extracellular vesicles induce apoptosis and restrain mitophagy-mediated degradation of damaged mitochondria","volume":"273","author":"Wang","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.jaci.2024.09.017_bib44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jid.2017.08.036","article-title":"Enhanced expression of genes related to xenobiotic metabolism in the skin of patients with atopic dermatitis but not with ichthyosis vulgaris","volume":"138","author":"Blunder","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib45","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.jid.2022.01.035","article-title":"Mitochondrial activity is upregulated in nonlesional atopic dermatitis and amenable to therapeutic intervention","volume":"142","author":"Leman","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jid.2022.08.048","article-title":"Quantitative proteomics identifies reduced NRF2 activity and mitochondrial dysfunction in atopic dermatitis","volume":"143","author":"Koch","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2024.09.017_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep22789","article-title":"From morphology to biochemical state\u2014intravital multiphoton fluorescence lifetime imaging of inflamed human skin","volume":"6","author":"Huck","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2024.09.017_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tma.2020.06.004","article-title":"ELOVL2: not just a biomarker of aging","volume":"4","author":"Chao","year":"2020","journal-title":"Transl Med Aging"},{"key":"10.1016\/j.jaci.2024.09.017_bib49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-022-00964-6","article-title":"Lipid metabolism dysfunction induced by age-dependent DNA methylation accelerates aging","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2024.09.017_bib50","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","article-title":"Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes","volume":"287","author":"Ginkel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2024.09.017_bib51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/mdc3.12610","article-title":"Progressive myoclonic epilepsy type 8 due to CERS1 deficiency: a novel mutation with prominent ataxia","volume":"5","author":"Godeiro Junior","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jaci.2024.09.017_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","article-title":"CerS1-derived C18:0 ceramide in skeletal muscle promotes obesity-induced insulin resistance","volume":"26","author":"Turpin-Nolan","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2024.09.017_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.20206","article-title":"The toppler mouse: a novel mutant exhibiting loss of Purkinje cells","volume":"476","author":"Duchala","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jaci.2024.09.017_bib54","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/s41467-018-05613-7","article-title":"A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism","volume":"9","author":"Turner","year":"2018","journal-title":"Nat Commun"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924009916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924009916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:52:08Z","timestamp":1738759928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924009916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0091674924009916"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.09.017","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}